Inactive Instrument

Rubius Therapeutics Stock price

Equities

RUBY

US78116T1034

Dynamic Chart
Managers TitleAgeSince
President 63 23-03-03
Investor Relations Contact - 18-05-31
Corporate Officer/Principal - 21-08-29
Members of the board TitleAgeSince
President 63 23-03-03
More insiders
Rubius Therapeutics, Inc. is a biopharmaceutical company. The Company is engaged in developing a platform and pipeline that is focused on creating cellular medicines called Red Cell Therapeutics. The Company's Red Cell Therapeutics are engineered to express biotherapeutic proteins within or on their cell surface to create selective and allogeneic cellular medicines for treating a range of diseases. Red Cell Therapeutics can also be used to kill tumors in cancer, regulate the immune system for the treatment of autoimmune diseases and treat a number of other types of illnesses. The Company's subsidiary is Rubius Therapeutics Securities Corporation.
Sector
-
More about the company
  1. Stock
  2. Equities
  3. Stock Rubius Therapeutics - OTC Markets